Trials / Completed
CompletedNCT01503957
Nasya in Allergic Rhinitis
Double-blind, Randomized, Placebo-controlled, Crossover Clinical Investigation to Evaluate Safety and Efficacy of Nasya in Reducing Symptoms of Allergic Rhinitis When Applied Before Allergen Challenge
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- InQpharm Group · Industry
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate safety and efficacy of Nasya in reducing symptoms of persistent allergic rhinitis when applied before allergen challenge.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Nasya | Thixotropic nasal spray suspension, 2 sprays in each nostril |
| DEVICE | Saline solution | Nasal spray, 2 sprays in each nostril |
Timeline
- Start date
- 2012-01-01
- Primary completion
- 2012-09-01
- Completion
- 2012-09-01
- First posted
- 2012-01-04
- Last updated
- 2012-10-26
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT01503957. Inclusion in this directory is not an endorsement.